Ligand validation:6P9V

ADN: ADENOSINE

ADN is a Ligand Of Interest in 6P9V designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6P9V_ADN_A_401	67%	64%	0.119	0.928	0.62	0.75	-	1	0	0	100%	1
5A1I_ADN_A_407	99%	50%	0.051	0.989	0.61	1.29	-	3	0	0	100%	0.5
8AXZ_ADN_A_407	92%	45%	0.089	0.979	0.87	1.23	-	2	0	0	100%	0.5
6FCD_ADN_A_405	91%	22%	0.069	0.956	1.31	1.92	2	4	0	0	100%	1
6FBO_ADN_A_406	90%	28%	0.074	0.955	1.34	1.55	3	4	0	0	100%	1
6FBP_ADN_B_404	58%	26%	0.118	0.894	0.96	1.98	1	5	0	0	100%	0.75
2ZBU_ADN_C_503	100%	25%	0.021	0.995	1.3	1.74	2	2	0	0	100%	1
4KAN_ADN_B_401	100%	24%	0.033	0.987	0.82	2.28	-	3	0	0	100%	1
3OND_ADN_B_507	99%	36%	0.049	0.983	1.21	1.3	1	1	0	0	100%	1
1VHW_ADN_E_252	99%	23%	0.048	0.978	1.55	1.6	4	4	0	0	100%	1
5KB6_ADN_B_401	99%	46%	0.052	0.981	0.69	1.38	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.